Empagliflozin vs Warfarin

Empagliflozin vs Warfarin: Overview

This comparison examines the pharmacological differences between Empagliflozin and Warfarin.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Warfarin: Inhibits vitamin K epoxide reductase complex.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Warfarin — 20-60 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Warfarin — C19H16O4.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Warfarin — 308.3280 g/mol.

Type: Empagliflozin — Small molecule; Warfarin — Small molecule.